scholarly journals Sleep Disorders in Multiple Sclerosis

Author(s):  
Montserrat González Platas ◽  
María Yaiza Pérez Martin
2015 ◽  
Vol 11 (05) ◽  
pp. 553-557 ◽  
Author(s):  
Zuzana Čarnická ◽  
Branislav Kollár ◽  
Pavel Šiarnik ◽  
Lucia Krížová ◽  
Katarína Klobučníková ◽  
...  

2010 ◽  
Vol 14 (2) ◽  
pp. 121-129 ◽  
Author(s):  
Steven D. Brass ◽  
Pierre Duquette ◽  
Joëlle Proulx-Therrien ◽  
Sanford Auerbach

2020 ◽  
Vol 36 (1) ◽  
pp. 41-57
Author(s):  
Karolina Katarelos ◽  
Agnieszka Piechal ◽  
Iwona Kurkowska-Jastrzębska

Sleep disorders is a common problem that patients report to their doctor. They can accompany many mental and somatic disorders or be primary. There are many types of sleep disorders; most commonly, they are associated with problems with falling asleep and maintaining sleep continuity, or more complex disorders, such as parasomnias, breathing disorders and movement disorders associated with sleep. In the following work, we have focused on sleep problems in patients with multiple sclerosis (MS). These patients more often than healthy people of the same age complain about sleep disorders and these dis­orders increase with the progress of the disease and the appearance of other symptoms. Depressed mood, chronic fatigue, pain and urinary problems significantly affect the quality of sleep in patients with MS. On the other hand, excessive sleepiness and trouble with falling asleep intensify the feeling of fatigue, which is a major problem and impair cognitive functions. However, sleep-related symptoms are often overlooked during medical visits due to other symptoms of multiple sclerosis, especially those causing motor disability. The treatment of sleep disorders in patients with MS is based on basic methods used in the general population. In the treatment of sleep disorders in patients with multiple sclerosis, appropriate disease modifying therapy is also important.


Author(s):  
G.N. Chuprуna

Studied sleep disorders (SD) in patients with multiple sclerosis (MS) using a Severity scale of insomnia (ІSІ) and Sleepiness Scale Epworth (ESS) in comparison with the control groups and in the aspect of comorbidity, as well as to determine the correlations between the SD and the degree of disability, the level of severity of fatigue, depression, pain, quality of life (QOL). The study involved 207 MS patients with different forms of cours and 109 people who constituted the control group. Evaluated the clinical and demographic characteristics of the patients with MS due to comorbidity, determines the level of disability (EDSS), severity of pain (VAS), the severity of fatigue (FSS), depression (BDI-II), indicators of QOL (SF-36). Single or multiple co-morbidities found in 102 (49.3%) patients with MS, there was no co-morbidities in 105 (50.7%) patients with MS. It was found that more often among the SD in the study group of patients with MS observed insomnia (54.1%). It led to a decrease in the total duration of a night's sleep, as well as mainly predispose hypersomnia (43.0%). Also found that patients with MS I and II groups SD were significantly more likely than the control groups. It is shown that in patients with MS II group have a more severe manifestations of insomnia and daytime sleepiness (DS), which is associated with the presence of comorbid disease. According to the correlation analysis shows that the degree of the SD in patients with MS is closely correlated with the level of fatigue were also observed close correlation between insomnia and DS.


Author(s):  
Sushanth Bhat ◽  
Sudhansu Chokroverty

While fatigue and excessive daytime sleepiness may coexist in many medical, neurological, and primary sleep disorders, they are distinct clinical symptoms that have different etiologies and treatment strategies. Making the distinction between fatigue and sleepiness is crucial to the management of a variety of conditions. This chapter provides an overview of fatigue from the perspective of the general practitioner, neurologist, and sleep specialist, and summarizes recent research developments in the field, including neuroimaging in fatigue. Emphasis is placed on the evaluation of fatigue in patients with a variety of neurological conditions (including multiple sclerosis, basal ganglia disorders, and post-polio fatigue), medical disorders, and sleep disorders, as well as on chronic fatigue syndrome.


Author(s):  
Luigi Ferini-Strambi ◽  
Sara Marelli

Though often unrecognized, sleep disorders in MS are seen at higher frequency than the general population, and they may contribute to pain, fatigue and depression—symptoms commonly observed in MS patients. Since several immunological factors in serum have been implicated in the development of sleep disorders, and MS is proven to be characterized by immune abnormalities, the notion that MS and sleep disorders share a similar background seems reasonable. Investigation of sleep disorders in MS is important, especially considering that the treatment of sleep disturbance may contribute to a reduction in debilitating symptoms, such as fatigue. Thus, an increased clinical awareness and appropriate treatment of sleep disorders in the MS population may significantly improve the overall quality of life in these patients.


2014 ◽  
Vol 10 (09) ◽  
pp. 1025-1031 ◽  
Author(s):  
Steven D. Brass ◽  
Chin-Shang Li ◽  
Sanford Auerbach

Sign in / Sign up

Export Citation Format

Share Document